Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.
2.

The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells.

Kurakula K, Vos M, Otermin Rubio I, Marinković G, Buettner R, Heukamp LC, Stap J, de Waard V, van Tiel CM, de Vries CJ.

PLoS One. 2014 Apr 15;9(4):e94931. doi: 10.1371/journal.pone.0094931. eCollection 2014.

3.

Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.

König K, Diehl L, Rommerscheidt-Fuss U, Golletz C, Quast T, Kahl P, Kolanus W, Knolle P, Buettner R, Heukamp LC.

J Immunol. 2010 Aug 1;185(3):1466-75. doi: 10.4049/jimmunol.0903449. Epub 2010 Jun 30.

4.

FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.

Hayashi H, Nakagami H, Takami Y, Koriyama H, Mori M, Tamai K, Sun J, Nagao K, Morishita R, Kaneda Y.

Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):909-14. doi: 10.1161/ATVBAHA.108.178541. Epub 2009 Mar 26. Erratum in: Arterioscler Thromb Vasc Biol. 2009 Dec 1;29(12):e132.

5.

FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.

Sun J, Yan G, Ren A, You B, Liao JK.

Circ Res. 2006 Sep 1;99(5):468-76. Epub 2006 Aug 3.

6.

Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury.

Mause SF, Ritzel E, Liehn EA, Hristov M, Bidzhekov K, Müller-Newen G, Soehnlein O, Weber C.

Circulation. 2010 Aug 3;122(5):495-506. doi: 10.1161/CIRCULATIONAHA.109.909473. Epub 2010 Jul 19.

7.

Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.

Huang PH, Chen CY, Lin CP, Wang CH, Tsai HY, Lo WY, Leu HB, Chen JW, Lin SJ, Chu PH.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):709-17. doi: 10.1161/ATVBAHA.112.300318. Epub 2013 Feb 14.

8.

Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity.

Poitevin S, Cussac D, Leroyer AS, Albinet V, Sarlon-Bartoli G, Guillet B, Hubert L, Andrieu-Abadie N, Couderc B, Parini A, Dignat-George F, Sabatier F.

Cardiovasc Res. 2014 Jul 1;103(1):121-30. doi: 10.1093/cvr/cvu104. Epub 2014 Apr 17.

PMID:
24743591
9.

The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.

Nouët Y, Dahan J, Labalette C, Levillayer F, Julien B, Jouvion G, Cairo S, Vives FL, Ribeiro A, Huerre M, Colnot S, Perret C, Nhieu JT, Tordjmann T, Buendia MA, Wei Y.

J Hepatol. 2012 Nov;57(5):1029-36. doi: 10.1016/j.jhep.2012.06.035. Epub 2012 Jul 11.

PMID:
22796152
10.

The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.

Hua G, He C, Lv X, Fan L, Wang C, Remmenga SW, Rodabaugh KJ, Yang L, Lele SM, Yang P, Karpf AR, Davis JS, Wang C.

Cell Death Dis. 2016 Jul 14;7:e2297. doi: 10.1038/cddis.2016.207.

11.

Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury.

Hristov M, Gümbel D, Lutgens E, Zernecke A, Weber C.

Circulation. 2010 Jan 19;121(2):315-24. doi: 10.1161/CIRCULATIONAHA.109.862771. Epub 2010 Jan 4.

12.

Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.

Lai CF, Bai S, Uthgenannt BA, Halstead LR, McLoughlin P, Schafer BW, Chu PH, Chen J, Otey CA, Cao X, Cheng SL.

J Bone Miner Res. 2006 Jan;21(1):17-28. Epub 2005 Oct 3.

13.

Deficiency in the LIM-only protein Fhl2 impairs skin wound healing.

Wixler V, Hirner S, Müller JM, Gullotti L, Will C, Kirfel J, Günther T, Schneider H, Bosserhoff A, Schorle H, Park J, Schüle R, Buettner R.

J Cell Biol. 2007 Apr 9;177(1):163-72.

14.

Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.

Endtmann C, Ebrahimian T, Czech T, Arfa O, Laufs U, Fritz M, Wassmann K, Werner N, Petoumenos V, Nickenig G, Wassmann S.

Hypertension. 2011 Sep;58(3):394-403. doi: 10.1161/HYPERTENSIONAHA.110.169193. Epub 2011 Aug 8.

15.

Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice.

Huss S, Stellmacher C, Goltz D, Khlistunova I, Adam AC, Trebicka J, Kirfel J, Büttner R, Weiskirchen R.

BMC Gastroenterol. 2013 Jan 14;13:8. doi: 10.1186/1471-230X-13-8.

16.

Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes.

Stathopoulou K, Cuello F, Candasamy AJ, Kemp EM, Ehler E, Haworth RS, Avkiran M.

Biochem J. 2014 Feb 1;457(3):451-61. doi: 10.1042/BJ20131026.

17.

Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.

Liu Y, Saiyan S, Men TY, Gao HY, Wen C, Liu Y, Zhou X, Wu CT, Wang LS, Cui CP.

J Pathol. 2013 Aug;230(4):365-76. doi: 10.1002/path.4194.

PMID:
23839903
18.

The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells.

Wong CH, Mak GW, Li MS, Tsui SK.

Cytokine. 2012 Aug;59(2):286-93. doi: 10.1016/j.cyto.2012.04.044. Epub 2012 May 24.

PMID:
22633286
19.

Sphingosine kinase-dependent activation of endothelial nitric oxide synthase by angiotensin II.

Mulders AC, Hendriks-Balk MC, Mathy MJ, Michel MC, Alewijnse AE, Peters SL.

Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2043-8. Epub 2006 Jul 20.

20.

The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcription.

Renger A, Zafiriou MP, Noack C, Pavlova E, Becker A, Sharkova K, Bergmann MW, El-Armouche A, Zimmermann WH, Zelarayán LC.

Stem Cells. 2013 May;31(5):928-40. doi: 10.1002/stem.1332.

Supplemental Content

Support Center